【摘 要】
:
BACKGROUND Although pathological response is a common endpoint used to assess the efficacy of neoadjuvant chemotherapy (NAC) for gastric cancer, the problem of
【机 构】
:
DivisionofGastrointestinalOncology,DivisionofPathology,DivisionofGastricSurgery,ClinicalResearchCent